高级检索
    于丁, 廖宁. 拉帕替尼联合卡培他滨治疗HER2过表达晚期乳腺癌的疗效评价[J]. 循证医学, 2008, 8(3): 140-142. DOI: 10.3969/j.issn.1671-5144.2008.03.005
    引用本文: 于丁, 廖宁. 拉帕替尼联合卡培他滨治疗HER2过表达晚期乳腺癌的疗效评价[J]. 循证医学, 2008, 8(3): 140-142. DOI: 10.3969/j.issn.1671-5144.2008.03.005
    shu
    YU Ding, LIAO Ning. The Therapeutic Effect Evaluafion of Lapalinib Plus Capecitabine for HER2 Positive Advanced Breast Cancer[J]. Journal of Evidence-Based Medicine, 2008, 8(3): 140-142. DOI: 10.3969/j.issn.1671-5144.2008.03.005
    Citation: YU Ding, LIAO Ning. The Therapeutic Effect Evaluafion of Lapalinib Plus Capecitabine for HER2 Positive Advanced Breast Cancer[J]. Journal of Evidence-Based Medicine, 2008, 8(3): 140-142. DOI: 10.3969/j.issn.1671-5144.2008.03.005
    shu

    拉帕替尼联合卡培他滨治疗HER2过表达晚期乳腺癌的疗效评价

    The Therapeutic Effect Evaluafion of Lapalinib Plus Capecitabine for HER2 Positive Advanced Breast Cancer

      摘要
      • HTML全文
      • 参考文献(0)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回